www.veteranstoday.com
Pfizer: “An application to extend Pfizer and BioNTech’s Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine marketing authorization in the EU to include children ages 6 months through 4 years is under discussion with the European Medicines Agency (EMA)”
by Fabio Giuseppe Carlo Carisio
All linked articles in Italian version are available in English with simultaneous machine translation
The Food and Drug Administration on Thursday authorized updated COVID shots that target the Omicron variant for children as young as 6 months old.
The eligibility rules vary depending on whether children received Moderna’s or Pfizer’s original vaccines as their primary series. Children 6 months through 5 years old who received Moderna’s two-dose primary series are now eligible for an Omicron booster two months after their second shot.
Kids ages 6 months through 4 years old who have not yet received the third dose of Pfizer’s primary series will now receive the Omicron shot as their third dose. But kids in the same age group who have already completed Pfizer’s three-dose primary series cannot get the Omicron shot as a booster, or fourth dose, at this time.
